Serum concentrations of aminoacylase 1 in schizophrenia as a potential biomarker: a case-sibling-control study.

This study is the first to evaluate the serum ACY1 levels in patients with schizophrenia. The result of the study provides us insight regarding the first hints that ACY1 might be a potential biomarker. Being aware of the molecule will pave the way for further explorations in the field.